BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18692359)

  • 1. Trends in the use of opioids at the end of life and the expected effects on hastening death.
    Rurup ML; Borgsteede SD; van der Heide A; van der Maas PJ; Onwuteaka-Philipsen BD
    J Pain Symptom Manage; 2009 Feb; 37(2):144-55. PubMed ID: 18692359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs used to alleviate symptoms with life shortening as a possible side effect: end-of-life care in six European countries.
    Bilsen J; Norup M; Deliens L; Miccinesi G; van der Wal G; Löfmark R; Faisst K; van der Heide A;
    J Pain Symptom Manage; 2006 Feb; 31(2):111-21. PubMed ID: 16488344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-of-life decision making in neonates and infants: comparison of The Netherlands and Belgium (Flanders).
    Vrakking AM; van der Heide A; Provoost V; Bilsen J; van der Wal G; Deliens L
    Acta Paediatr; 2007 Jun; 96(6):820-4. PubMed ID: 17537009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-of-life decisions in Australian medical practice.
    Kuhse H; Singer P; Baume P; Clark M; Rickard M
    Med J Aust; 1997 Feb; 166(4):191-6. PubMed ID: 9066548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [No conspicuous changes in the practice of medical end-of-life decision-making for neonates and infants in the Netherlands in 2001 as compared to 1995].
    Vrakking AM; van der Heide A; Onwuteaka-Philipsen BD; Keij-Deerenberg IM; van der Maas PJ; van der Wal G
    Ned Tijdschr Geneeskd; 2005 Sep; 149(37):2047-51. PubMed ID: 16184946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requests to forgo potentially life-prolonging treatment and to hasten death in terminally ill cancer patients: a prospective study.
    Georges JJ; Onwuteaka-Philipsen BD; van der Heide A; van der Wal G; van der Maas PJ
    J Pain Symptom Manage; 2006 Feb; 31(2):100-10. PubMed ID: 16488343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study.
    Reuzel RP; Hasselaar GJ; Vissers KC; van der Wilt GJ; Groenewoud JM; Crul BJ
    Palliat Med; 2008 Jul; 22(5):641-6. PubMed ID: 18612030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and determinants of end-of-life practices in ALS in the Netherlands.
    Maessen M; Veldink JH; Onwuteaka-Philipsen BD; de Vries JM; Wokke JH; van der Wal G; van den Berg LH
    Neurology; 2009 Sep; 73(12):954-61. PubMed ID: 19770471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid use and survival at the end of life: a survey of a hospice population.
    Portenoy RK; Sibirceva U; Smout R; Horn S; Connor S; Blum RH; Spence C; Fine PG
    J Pain Symptom Manage; 2006 Dec; 32(6):532-40. PubMed ID: 17157755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of physicians' life stances on attitudes to end-of-life decisions and actual end-of-life decision-making in six countries.
    Cohen J; van Delden J; Mortier F; Löfmark R; Norup M; Cartwright C; Faisst K; Canova C; Onwuteaka-Philipsen B; Bilsen J;
    J Med Ethics; 2008 Apr; 34(4):247-53. PubMed ID: 18375674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain.
    Nwokeji ED; Rascati KL; Brown CM; Eisenberg A
    Clin Ther; 2007; 29 Suppl():2589-602. PubMed ID: 18164924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals.
    Orsey AD; Belasco JB; Ellenberg JH; Schmitz KH; Feudtner C
    Pediatr Blood Cancer; 2009 Jul; 52(7):761-6. PubMed ID: 18989880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in medical end-of-life practices during the legalization process of euthanasia in Belgium.
    Bilsen J; Vander Stichele R; Broeckaert B; Mortier F; Deliens L
    Soc Sci Med; 2007 Aug; 65(4):803-8. PubMed ID: 17490798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous palliative sedation for cancer and noncancer patients.
    Swart SJ; Rietjens JA; van Zuylen L; Zuurmond WW; Perez RS; van der Maas PJ; van Delden JJ; van der Heide A
    J Pain Symptom Manage; 2012 Feb; 43(2):172-81. PubMed ID: 21925832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous deep sedation: physicians' experiences in six European countries.
    Miccinesi G; Rietjens JA; Deliens L; Paci E; Bosshard G; Nilstun T; Norup M; van der Wal G;
    J Pain Symptom Manage; 2006 Feb; 31(2):122-9. PubMed ID: 16488345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalisations at the end of life: using a sentinel surveillance network to study hospital use and associated patient, disease and healthcare factors.
    Van den Block L; Deschepper R; Drieskens K; Bauwens S; Bilsen J; Bossuyt N; Deliens L
    BMC Health Serv Res; 2007 May; 7():69. PubMed ID: 17488520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians' attitudes towards end-of-life decisions: a comparison between seven countries.
    Miccinesi G; Fischer S; Paci E; Onwuteaka-Philipsen BD; Cartwright C; van der Heide A; Nilstun T; Norup M; Mortier F;
    Soc Sci Med; 2005 May; 60(9):1961-74. PubMed ID: 15743647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End of life decision-making by New Zealand general practitioners: a national survey.
    Mitchell K; Owens G
    N Z Med J; 2004 Jun; 117(1196):U934. PubMed ID: 15280938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical end-of-life decisions for children in the Netherlands.
    Vrakking AM; van der Heide A; Arts WF; Pieters R; van der Voort E; Rietjens JA; Onwuteaka-Philipsen BD; van der Maas PJ; van der Wal G
    Arch Pediatr Adolesc Med; 2005 Sep; 159(9):802-9. PubMed ID: 16143738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing of pain medication in palliative care. A survey in general practice.
    Borgsteede SD; Deliens L; Zuurmond WW; Schellevis FG; Willems DL; Van der Wal G; van Eijk JT
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):16-23. PubMed ID: 18985638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.